I'm adding a new stock to my watchlist. 
BCDA has Market Cap of 36.28 M and an Enterprise Value of 31.32 M. It has 31.3% insider ownership with the management buying shares each month since September 2022 through December 2022. They create cellular therapeutics for cardiovascular diseases. Their revenue has been growing 11% per year over the past 5 years. Price project is now set to $6.22 (344%) move in the future.
I see many are trapped in the $3.69 area.
Do your own due diligence not stock advice. Just my thoughts.
BCDA has Market Cap of 36.28 M and an Enterprise Value of 31.32 M. It has 31.3% insider ownership with the management buying shares each month since September 2022 through December 2022. They create cellular therapeutics for cardiovascular diseases. Their revenue has been growing 11% per year over the past 5 years. Price project is now set to $6.22 (344%) move in the future.I see many are trapped in the $3.69 area.
Do your own due diligence not stock advice. Just my thoughts.
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.